C Polgar
Overview
Explore the profile of C Polgar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hannoun-Levi J, Gutierrez C, Polgar C, Strnad V
Ann Oncol
. 2022 Jul;
33(10):1088.
PMID: 35803547
No abstract available.
2.
Bukovszky B, Fodor J, Szekely G, Kocsis S, Oberna F, Major T, et al.
Strahlenther Onkol
. 2022 Mar;
198(9):820-827.
PMID: 35357513
Purpose: To evaluate the mutagen sensitivity phenotype on the risk of second primary cancer (SPC) in patients with head and neck squamous cell carcinoma (HNSCC), and to estimate the long-term...
3.
Major T, Polgar C, Jorgo K, Stelczer G, Agoston P
Brachytherapy
. 2017 Mar;
16(3):608-615.
PMID: 28325472
Purpose: The aim of this study was to compare the dosimetry of intraoperative dose plans of prostate cancer patients treated with low-dose-rate (LDR) and high-dose-rate (HDR) interstitial brachytherapy (BT). Methods...
4.
Savolt A, Peley G, Polgar C, Udvarhelyi N, Rubovszky G, Kovacs E, et al.
Eur J Surg Oncol
. 2017 Feb;
43(4):672-679.
PMID: 28139362
Introduction: The National Institute of Oncology, Budapest conducted a single centre randomized clinical study. The OTOASOR (Optimal Treatment Of the Axilla - Surgery Or Radiotherapy) trial compares completion of axillary...
5.
Peppa V, Pappas E, Karaiskos P, Major T, Polgar C, Papagiannis P
Phys Med
. 2016 Oct;
32(10):1245-1251.
PMID: 27720277
Purpose: To investigate the clinical significance of introducing model based dose calculation algorithms (MBDCAs) as an alternative to TG-43 in Ir interstitial breast brachytherapy. Materials And Methods: A 57 patient...
6.
Ott O, Strnad V, Potter R, Hammer J, Hildebrandt G, Resch A, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:109-28.
PMID: 27137924
No abstract available.
7.
Zourari K, Major T, Herein A, Peppa V, Polgar C, Papagiannis P
Phys Med
. 2015 Jun;
31(7):669-76.
PMID: 26055951
Purpose: To compare dosimetry using a contemporary model based dose calculation algorithm (MBDCA) following TG186 recommendations, and the conventional TG43 method in an (192)Ir high dose rate (HDR) accelerated partial...
8.
Hitre E, Budai B, Takacsi-Nagy Z, Rubovszky G, Toth E, Remenar E, et al.
Br J Cancer
. 2013 Aug;
109(5):1117-22.
PMID: 23942070
Background: Epidermal growth factor receptor (EGFR) is highly expressed in adenoid cystic carcinoma (ACC). The efficacy and toxicity of cetuximab with concomitant platinum-based chemoradio- or chemotherapy in patients with locally...
9.
Arriagada R, Averbeck D, Dahl A, Darby S, Fossa S, FRIBERG S, et al.
Eur J Cancer
. 2008 Dec;
45(3):354-9.
PMID: 19081244
This Workshop was organised by the Organisation of European Cancer Institutes (OECI) to provide a forum for discussing the late side-effects resulting from different cancer treatments. One of the main...
10.
Fodor J, Major T, Polgar C, Orosz Z, Sulyok Z, Kasler M
Breast
. 2007 Dec;
17(3):302-8.
PMID: 18082403
Between 1983 and 1987, 1309 women with stage I or II breast cancer underwent mastectomy (n=894) or conservative surgery (CS, n=415). Of these patients, 124 developed an isolated local recurrence...